The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Strum Jay since 2018.
The trader's CIK number is 1706851.
At the time of the last reporting, Strum Jay was the Chief Scientific Officer of G1 Therapeutics, Inc.. (stock ticker symbol GTHX).
Also see all insider trading activities at G1 Therapeutics, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2019 | GTHX | 0 | $0 | 0 | $0 | 79,818 | $27,537 |
| 2018 | GTHX | 0 | $0 | 10,000 | $596,435 | 850 | $255 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-01-02 | GTHX | Option Ex | 79,818 | .34 | 27,537 |
| 2018-10-04 | GTHX | Option Ex | 850 | .30 | 255 |
| 2018-08-30 | GTHX | Sale | 5,000 | 59.66 | 298,300 |
| 2018-08-29 | GTHX | Sale | 5,000 | 59.63 | 298,135 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Strum Jay (Chief Scientific Officer of G1 Therapeutics, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.